TransMedics Group, Inc. Common Stock
TMDXStock
$76.00−34.84%52W
Market Cap$2.61B
P/E13.73x
Div yield—
Beta1.94
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-54.55%
Price vs S&P 500 (4W)-1.18%
VGM Score53.36
Market Capitalization$2.61B
P/E Ratio (Annual)13.73x
Earnings Surprise History
Q1 260.30est. 0.63
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.15
4.15
4.15
4.00
Industry Peers — Electromedical Equipment(32)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TMDXTransMedics Group, Inc. Common Stock | C | B | D | $76.00 |
| MDTMedtronic plc | B | C | C | $83.56 |
| MASIMasimo Corporation | D | D | C | $179.95 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $81.79 |
| ITGRInteger Holdings Corporation | B | C | B | $99.62 |
| AXGNAxogen, Inc. Common Stock | F | B | B | $39.77 |
| BLFSBioLife Solutions Inc. | F | B | A | $30.26 |
| CNMDCONMED Corporation | A | C | B | $45.01 |
| INMDInMode Ltd. Ordinary Shares | A | D | B | $15.60 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $19.14 |
| ELMDElectromed, Inc. | D | B | A | $42.80 |
About
TransMedics Group Inc develops the Organ Care System (OCS), a portable organ perfusion and monitoring platform that preserves donor organs in near-physiologic conditions outside the body. The company's technology addresses significant limitations of traditional cold storage preservation, potentially improving organ quality and transplant outcomes. As a commercial-stage medical technology company, TransMedics is expanding its organ preservation system across multiple transplant disease states.